Novartis Case Study
Cases
Novartis
The case of rejection of Novartis’ patent application for its cancer drug ‘Glivec’ is a classic example of the way India has incorporated appropriate safeguards in its patent laws to subdue the harmful effects of medical patents on accessibility of essential medicines. In this case, the safeguard is in the form on Section 3(d) of the Indian Patents Act, 1970.
Novartis had filed an application with the Indian Patent Office in 1998 for inventing a new form ‘Imatinib Mesylate’ of its earlier molecule ‘Imatinib’. It failed to prove increased pharmacological efficacy. The Indian Patent Office rejected the application.
In 2013, the Supreme Court upheld the rejection of the patent application filed by Novartis for Glivec before the
…show more content…
NATCO Pharma was granted the Compulsory Licence to produce the drug Nexavar that was patented by Bayer. In a significant decision that would have long-lasting consequences for availability of essential medicines, the Supreme Court of India refused to entertain Bayer’s Special Leave Petition to scrap CL on Nexavar granted to NATCO Pharma. The highest court upheld the Bombay High Court’s decision to uphold the CL. This is the first ever CL granted to any company in India.
The litigation ensuing around the Compulsory Licence application for Sorafenib tosylate (Nexavar), its grant, the petition to scrap it and the subsequent rejection of the petition, was the first of its kind in India. Sorafenib tosylate is a drug to cure kidney and liver cancer. The price that Bayer was charging for the drug under the trade name Nexavar was Rs. 2,84,000 per patient per month which is exorbitant for majority of the patients in India. In March 2012, the Patent Controller granted a CL to NATCO Pharma to manufacture and market a cheaper generic version of Nexavar at around Rs. 8,800 per person per year. Bayer subsequently appealed against the grant before the Intellectual Property Appellate Board (IPAB) and later before the Bombay High
Compound 17392
691 Words | 3 PagesA new oral pharmaceutical drug for type- two diabetes had been approved for clinical use, it was called Compound 17392. Marketing companies instantly wanted to have prescribers adopt and sell the product and researchers wanted to further investigate previous reports of liver toxicity in patients. Now since paying patients to try new pharmaceutical drugs was an issue due to it appearing to interfere with clinical judgement and upholding the duty to do what is best for the patient, a new idea of furthering research for the drug came into play. The idea included recruiting a group of physicians who were in the top ten percent of prescribers for type-two diabetes. Following regulations put in place by researchers, these physicians were to enter eligible patients into the trial for Compound
How Did Kevin Trudeau Put On Trial For Misleading Infomercials?
387 Words | 2 PagesIn 1998 Kevin Trudeau was put on trial for misleading infomercials. His infomercials were in violation of Section 5 and 12 of the FTC Act. He was forbidden from creating and hosting infomercials. He was required to pay $500,000 in customer-redress and the court held $500,000 of his funds. If he failed to pay the $500,000 in customer-redress then his $500,000 that was being held would become forfeit.
Case Study: Cornerstone Therapeutics, Inc.
604 Words | 3 PagesLast summer, the Delaware Supreme Court held that a lawsuit challenging an acquisition by a controlling shareholder seeking monetary damages against corporate fiduciaries must plead a non-exculpated claim against disinterested, independent directors to survive a motion to dismiss. The Court’s decision resolved two separate consolidated appeals by directors of Cornerstone Therapeutics, Inc. and Zhongpin, Inc. In each case, the Delaware Chancery Court denied the independent directors' motions to dismiss, analyzing that if the underlying transaction is subject to the “entire fairness” standard of review, all of the directors must remain defendants until the end of the litigation, regardless of any exculpatory language contained in the companies’ charter provisions.. In reversing on appeal, the Delaware Supreme Court held:
Crichton Vs Calfee Summary
587 Words | 3 PagesPaper 2 A person who owns a small portion of someone's genes may be the deciding factor on whether a person's illness is further researched or put on hold. Should a person be given this much power over our very genes inside us whose research could save lives and cure diseases? A physician, Michael Crichton, who wrote “Patenting Life” and a economist, John Calfee, who wrote “Decoding the Use of Gene Patents” both discuss this medicinal dilemma.
Summary Of Bowman Vs Monsanto
719 Words | 3 PagesToday on this exam, I will be focusing on a Supreme Court case that was heard during the 2012-13 term. The case that I’m doing is named, “Bowman v. Monsanto”. This Supreme Court case focuses on the dealing of seeds and patents incorporated into their genetic material. Bowman versus Monsanto was argued on February 19th, 2013 and granted on October 5th, 2013.
NSQHS Medication Safety Case Study
403 Words | 2 PagesThe coroner found toxicology to be the result of respiratory depression and the main cause of death of Mrs Herbert. Therefore it is evident from this result that standard 4, medication safety was breached by the health care workers involved within this case. The NSQHS medication safety criteria consists of a number of safety measures health care workers need to meet when handling medications including prescribing, supplying, administering, storing and monitoring patients post administration (Australian Commission on Safety and Quality in Health Care 2012). In this event, the doctor and nurses did not meet this safety requirement when caring for Mrs Herbert. Dr Kurtzer decided to administer an intramuscular injection of 30mg of morphine due
Cvs Caremark Case Study
247 Words | 1 PagesRespectful and supportive work environment CVS Caremark is committed to providing their employee with a respectful and supportive environment. Collaboration and teamwork are valued and colleagues are recognized and rewarded for their contributions. This commitment has enabled the company to attract and retain talented individuals who have contributed to the growth and success of CVS Caremark. Astute Hiring Practices CVS excels in teambuilding due to their astute hiring practices and the processes in place of keeping their employees engaged. (CVS, 2010).
Margaret Sanger And Birth Control
1227 Words | 5 PagesBirth control hasn’t always been legal for women in the United States. In 1873 the Comstock Act passing prohibiting advertisements, information, and distribution of birth control. This act also allowed the postal service to confiscate any information or birth control sold through the mail. Margaret Sanger made it her life’s work to make information about birth control and birth control itself available to women in the United States. Margaret Sanger was a nurse on the Lower East Side of New York City and decided to get involved in the Birth Control Movement in 1912 after she watched a woman die as a result of a self-induced abortion.
The Kefauver-Harris Drug Amendment Act
866 Words | 4 PagesThe Kefauver-Harris Drug Amendment Act Kefauver-Harris Drug Amendment Act 1962 During the 20th century, no federal regulations were in place to protect citizen from receiving dangerous drugs. However, today drugs undergo rigorous evaluations of safety, quality, and effectiveness before they are available to the public. President John F. Kennedy signed the Kefauver-Harris Drug Amendment Act into law.
Novo Nordisk Case Study
125 Words | 1 PagesNovo Nordisk prides itself in keeping their Triple Bottom Line and that is something I truly appreciate because it takes the ethical implications presented in my introductory courses and demonstrates that it is possible to be successful and benefit the surrounding social and economic environment at the same time. Thus, if I am chosen for this program I will bring my unique leadership style, intellectual acuity, and professionalism to work successfully with a team and aid the various departments in any projects available. I would be honored to join Novo Nordisk this summer and learn an immense amount from talented professionals and fellow colleagues alike. Overall, I am immensely grateful for your consideration and look forward to the opportunity
Captopril Essay
381 Words | 2 PagesHistory of Captopril In the mid of 1950s, angiotensin converting enzyme (ACE) was identified as the enzyme which converts angiotensin I to angiotensin II (vasoconstrictor substance). The cause of hypertension was actively investigated by John R. Vane in the 1960s. In 1967, Kevin K.F. Ng found the angiotensin I converts to angiotensin II in pulmonary circulation. During this time, Sergio Ferreira joined Vane’s team.
Medical Office Procedures Research Paper
440 Words | 2 PagesAAS- Medical Office Procedures Week 2 Discussion Judy Potts Explain why pharmaceutical representatives leave samples of expensive medications with physicians. Pharmaceutical representatives, show the physicians the newest drugs on the market, to drum up business for the pharmaceutical companies. The representatives leave samples of the products, In hopes that the doctor will strat prescribing their new name brand products for his patients instead of generic drugs. Also, in some cases, the patients are not financially able to purchase a new drug not knowing if it will help with their disease. The clinic 's management staff will determine whether they will be except the newest medication samples from the representative.
My Reflection On Medication History
831 Words | 4 PagesOne of many important aspects of a medication history is determining how knowledgeable a patent is about their medications and their disease states. For the medication knowledge I feel that this means that the patient can identify which drug treats which disease state, how to correctly use the drug and how often, and when to get help if experiencing side effects or if
Porter's Five Forces Analysis Pharmaceutical Industry
720 Words | 3 PagesMany new companies to enter the market without burden of costly tasks such as research and development, clinical trials and manufacturing of drugs. Moreover, patent expiry is one of the reasons which is offering opportunities for lower cost generic manufacturer in terms of greater market access. Additionally, the government has increased their focus on healthcare cost cutting. It is creating pressure on the authority to allow early introduction of low-cost drugs in the
Case Study: Janssen Pharmaceutica '
1472 Words | 6 PagesJanssen Pharmaceutica Janssen is one of the world’s leading research based pharmaceutical organisations and is part of the Johnson and Jonson family of companies. J&J is a diverse group of healthcare specialists. Johnson and Johnson was founded in 1886 and is an American pharmaceutical, medical devices and consumer packages goods manufacture. Janssen Pharmaceutical Companies of Johnson & Johnson, is dedicated to research and development of new drugs against the most important unmet medical needs of this generation, including oncology, infectious disease, neuroscience, cardiovascular and metabolic diseases and immunology.
More about Novartis Case Study
Compound 17392
691 Words | 3 PagesHow Did Kevin Trudeau Put On Trial For Misleading Infomercials?
387 Words | 2 PagesCase Study: Cornerstone Therapeutics, Inc.
604 Words | 3 PagesCrichton Vs Calfee Summary
587 Words | 3 PagesSummary Of Bowman Vs Monsanto
719 Words | 3 PagesNSQHS Medication Safety Case Study
403 Words | 2 PagesCvs Caremark Case Study
247 Words | 1 PagesMargaret Sanger And Birth Control
1227 Words | 5 PagesThe Kefauver-Harris Drug Amendment Act
866 Words | 4 PagesNovo Nordisk Case Study
125 Words | 1 PagesCaptopril Essay
381 Words | 2 PagesMedical Office Procedures Research Paper
440 Words | 2 PagesMy Reflection On Medication History
831 Words | 4 PagesPorter's Five Forces Analysis Pharmaceutical Industry
720 Words | 3 PagesCase Study: Janssen Pharmaceutica '
1472 Words | 6 Pages